TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group.
Karschnia P, Young JS, Dono A, Häni L, Juenger ST, Sciortino T, Bruno F, Teske N, Morshed RA, Haddad AF, Zhang Y, Stoecklein S, Vogelbaum MA, Beck J, Tandon N, Hervey-Jumper S, Molinaro AM, Rudà R, Bello L, Schnell O, Esquenazi Y, Ruge MI, Grau SJ, van den Bent M, Weller M, Berger MS, Chang SM, Tonn JC.
Karschnia P, et al. Among authors: ruge mi.
Neurooncol Adv. 2022 Sep 29;4(1):vdac158. doi: 10.1093/noajnl/vdac158. eCollection 2022 Jan-Dec.
Neurooncol Adv. 2022.
PMID: 36325373
Free PMC article.
No abstract available.